advertisement
Molecular Neurodegeneration 12
Showing records 1 to 12 |
Display all abstracts in Molecular Neurodegeneration94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucomaBelforte N
Molecular Neurodegeneration 2021; 16: 43
94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucomaRisner ML; Pasini S
Molecular Neurodegeneration 2021; 16: 36
94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucomaAgostinone J; Alarcon-Martinez L
Molecular Neurodegeneration 2021; 16: 43
94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucomaMcGrady NR
Molecular Neurodegeneration 2021; 16: 36
94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucomaVillafranca-Baughman D
Molecular Neurodegeneration 2021; 16: 43
94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucomaD'Alessandro KB
Molecular Neurodegeneration 2021; 16: 36
94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucomaDotigny F
Molecular Neurodegeneration 2021; 16: 43
94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucomaYao V
Molecular Neurodegeneration 2021; 16: 36
94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucomaCueva Vargas JL
Molecular Neurodegeneration 2021; 16: 43
94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucomaCooper ML
Molecular Neurodegeneration 2021; 16: 36
94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucomaDi Polo A
Molecular Neurodegeneration 2021; 16: 43
94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucomaCalkins DJ
Molecular Neurodegeneration 2021; 16: 36
Issue 22-2
Change Issue
advertisement